Advertisement
The American Journal of Cardiology®
Advanced SearchSave search
Readers' Comments| Volume 117, ISSUE 2, P312-313, January 15, 2016

The Use of Novel Oral Anticoagulants in Adult Congenital Heart Disease: A Single Center Experience

Published:November 11, 2015DOI:https://doi.org/10.1016/j.amjcard.2015.11.002
The Use of Novel Oral Anticoagulants in Adult Congenital Heart Disease: A Single Center Experience
Previous ArticleStatins for Improving Myocardial Perfusion in Patients With Nonalcoholic Fatty Liver Disease Undergoing Percutaneous Coronary Intervention
Next ArticleAnti-Inflammatory Role of Statins in Preventing Postoperative Atrial Fibrillation
      We read the study by Niesert et al in a recent edition of the American Journal of Cardiology. The investigators present the first clinical evidence on the use of novel oral anticoagulants (NOACs) in adult congenital heart disease (ACHD). In their study, 55 patients with congenital heart disease were started on NOACs. Median follow-up was 6 months and during this period only one NOAC therapy was stopped as a result of bleeding.
      • Niesert A.C.
      • Pujol C.
      • Engelhardt A.
      • Lummert E.
      • Schön P.
      • Braun S.
      • Ewert P.
      • Kaemmerer H.
      OP-047 initial experience on the use of novel oral anticoagulants (NOAC) in adults with congenital heart disease.
      Am J Cardiol. 2015; 115: S21
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Niesert A.C.
        • Pujol C.
        • Engelhardt A.
        • Lummert E.
        • Schön P.
        • Braun S.
        • Ewert P.
        • Kaemmerer H.
        OP-047 initial experience on the use of novel oral anticoagulants (NOAC) in adults with congenital heart disease.
        Am J Cardiol. 2015; 115: S21
        View in Article
        • Bouchardy J.
        • Therrien J.
        • Pilote L.
        • Ionescu-Ittu R.
        • Martucci G.
        • Bottega N.
        • Marelli A.J.
        Atrial arrhythmias in adults with congenital heart disease.
        Circulation. 2009; 120: 1679-1686
        View in Article
        • Jensen A.S.
        • Idorn L.
        • Nørager B.
        • Vejlstrup N.
        • Sondergaard L.
        Anticoagulation in adults with congenital heart disease: the who, the when and the how?.
        Heart. 2015; 101: 424-429
        View in Article
        • Connolly S.J.
        • Ezekowitz M.D.
        • Yusuf S.
        • Eikelboom J.
        • Oldgren J.
        • Parekh A.
        • Pogue J.
        • Reilly P.A.
        • Themeles E.
        • Varrone J.
        • Wang S.
        • Alings M.
        • Xavier D.
        • Zhu J.
        • Diaz R.
        • Lewis B.S.
        • Darius H.
        • Diener H.C.
        • Joyner C.D.
        • Wallentin L.
        • RE-LY Steering Committee and Investigators
        Dabigatran versus warfarin in patients with atrial fibrillation.
        N Engl J Med. 2009; 361: 1139-1151
        View in Article
        • Anderson J.L.
        • Halperin J.L.
        • Albert N.M.
        • Bozkurt B.
        • Brindis R.G.
        • Curtis L.H.
        • DeMets D.
        • Guyton R.A.
        • Hochman J.S.
        • Kovacs R.J.
        • Ohman E.M.
        • Pressler S.J.
        • Sellke F.W.
        • Shen W.K.
        • Wann L.S.
        • Curtis A.B.
        • Ellenbogen K.A.
        • Estes 3rd, N.A.
        • Ezekowitz M.D.
        • Jackman W.M.
        • January C.T.
        • Lowe J.E.
        • Page R.L.
        • Slotwiner D.J.
        • Stevenson W.G.
        • Tracy C.M.
        • Fuster V.
        • Rydén L.E.
        • Cannom D.S.
        • Crijns H.J.
        • Curtis A.B.
        • Ellenbogen K.A.
        • Le Heuzey J.Y.
        • Kay G.N.
        • Olsson S.B.
        • Prystowsky E.N.
        • Tamargo J.L.
        • Wann S.
        Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
        J Am Coll Cardiol. 2013; 61: 1935-1944
        View in Article
        • Skanes A.C.
        • Healey J.S.
        • Cairns J.A.
        • Dorian P.
        • Gillis A.M.
        • McMurtry M.S.
        • Mitchell L.B.
        • Verma A.
        • Nattel S.
        • Cardiovascular Society Atrial Fibrillation Guidelines Committee
        Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.
        Can J Cardiol. 2012; 28: 125-136
        View in Article
        • Khairy P.
        • Van Hare G.F.
        • Balaji S.
        • Berul C.I.
        • Cecchin F.
        • Cohen M.I.
        • Daniels C.J.
        • Deal B.J.
        • Dearani J.A.
        • Nd Groot
        • Dubin A.M.
        • Harris L.
        • Janousek J.
        • Kanter R.J.
        • Karpawich P.P.
        • Perry J.C.
        • Seslar S.P.
        • Shah M.J.
        • Silka M.J.
        • Triedman J.K.
        • Walsh E.P.
        • Warnes C.A.
        PACES/HRS expert consensus statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD).
        Heart rhythm. 2014; 11: e102-e165
        View in Article

      8. Report of the Fifth European Meeting on Adult Congenital Heart Disease, 10–11 April 2014, Amsterdam, Netherlands. Available at: http://www.escardio.org/The-ESC/Communities/Working-Groups/Working-Group-on-Grown–up-Congenital-Heart-Disease/Education/Report-of-the-Fifth-European-meeting-on-Adult-Congenital-Heart-Disease-10-11-Ap. Accessed on November 1, 2015.

        View in Article

      9. NOTE registry. Available at: http://www.isachd.org/content/note-registry. Accessed on November 1, 2015.

        View in Article

      Article Info

      Publication History

      Published online: November 11, 2015
      Received: November 1, 2015

      Footnotes

      Drs. Cheng and Harrogate contributed equally to this Readers' Comments.

      Identification

      DOI: https://doi.org/10.1016/j.amjcard.2015.11.002

      Copyright

      © 2016 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      Linked Article

      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX